GlassScriptPhysician profile
Dana M Putman
NPI 1922330208
$399.43
in general payments reported to CMS, 2019-2025
10 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $95.12 · 2024: $90.02 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $130.74 | 2023-2025 | Phexxi, Solosec, Phexx |
| Sage Therapeutics, LLC | $66.59 | 2025 | Zurzuvae |
| Lilly USA, LLC | $48.14 | 2023 | Mounjaro, Trulicity |
| Shield Therapeutics INC | $45.35 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $24.00 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $23.24 | 2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $17.77 | 2025 | |
| Abbvie INC. | $17.32 | 2023 | |
| Exact Sciences Corporation | $13.27 | 2023 | Cologuard Collection Kit |
| Organon LLC | $13.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Putman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.